Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor - Te-Ling Lu; Wei-Ting Chang; Chee-Hong Chan; Sheng-Nan Wu (Frontiers in Pharmacology, 2019)
Keywords: delayed-rectifier K+ current; erg-mediated K+ current; M-type K+ current; membrane potential; Pharmacology; pituitary cell; RM1-950; Therapeutics. Pharmacology; tolvaptan